Technology
Health
Biotechnology

Summit Therapeutics

$1.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.47%) Today
-$0.01 (-0.47%) Today

Why Robinhood?

You can buy or sell SMMT and other stocks, options, ETFs, and crypto commission-free!

About

Summit Therapeutics plc American Depositary Shares, also called Summit Therapeutics, is a holding company, which engages in the discovery, development, and commercialization of novel medicines. It focuses on the genetic disease duchenne muscular dystrophy, and the infectious disease clostridium difficile infection. Read More The company was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, United Kingdom.

Employees
76
Headquarters
Abingdon, Oxfordshire
Founded
2004
Market Cap
31.75M
Price-Earnings Ratio
Dividend Yield
Average Volume
90.45K
High Today
$1.97
Low Today
$1.90
Open Price
$1.90
Volume
10.39K
52 Week High
$14.29
52 Week Low
$1.10

Collections

Technology
Health
Biotechnology
Therapy
2015 IPO
UK
Europe

News

Markets InsiderFeb 26

6 Top Gainers In Healthcare Sector (SMMT, HTBX, NTGN...)

(RTTNews) - The following are some of today's top gainers in the pharma/biotech sector. 1. Summit Therapeutics plc (SMMT) Gained 28.97% to close Tuesday's (Feb.26) trading at $1.87. News: The Company announced that preclinical data on SMT-571, which is in development for the treatment of gonorrhoea, shows that the compound is potent against diverse, global Neisseria gonorrhoeae strains from actual patient cases, including numerous multi- and extensively-drug resistant strains. Clinical Trials & Near-ter...

253
Yahoo FinanceFeb 19

New Research Coverage Highlights Global Payments, Tableau Software, Summit Therapeutics, Utah Medical Products, Apollo Commercial Real Estate Finance, and Urstadt Biddle Properties — Consolidated Reve

NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Global Payments Inc. (GPN), Tableau Software, Inc. (DATA), Summit Therapeutics PLC (SMMT), Utah Medical Products, Inc. (UTMD), Apollo Commercial Real Estate Finance (ARI), and Urstadt Biddle Properties Inc. (UBA), including updated fundamental summaries, consolidated fiscal reporting, and f...

54

Earnings

-$0.53
-$0.21
$0.10
$0.42
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.